Barclays’s Bruker BRKR Stock Holding History

Barclays’s Portfolio BRKR Stock Details BRKR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-400	Closed	-$20K	–	6148
2019 Q4	$20K	Buy	+400	New	+$19K	﹤0.01%	5981
2019 Q3	–	Sell	-23,300	Closed	-$1.16M	–	6721
2019 Q2	$1.16M	Buy	+23,300	New	+$982K	﹤0.01%	3529
2018 Q4	–	Sell	-3,100	Closed	-$104K	–	6953
2018 Q3	$104K	Buy	+3,100	New	+$102K	﹤0.01%	5506
2018 Q2	–	Sell	-500	Closed	-$15K	–	6978
2018 Q1	$15K	Buy	+500	New	+$16.2K	﹤0.01%	6523
2017 Q3	–	Sell	-800	Closed	-$23K	–	6842
2017 Q2	$23K	Sell	800 -2,200	-73%	-$56.6K	﹤0.01%	5725
2017 Q1	$70K	Sell	3,000 -200	-6%	-$4.7K	﹤0.01%	5130
2016 Q4	$68K	Buy	+3,200	New	+$70K	﹤0.01%	4973
2015 Q4	–	Sell	-5,900	Closed	-$94K	–	6007
2015 Q3	$94K	Buy	+5,900	New	+$115K	﹤0.01%	4654
2015 Q2	–	Sell	-35,000	Closed	-$630K	–	7012
2015 Q1	$630K	Buy	+35,000	New	+$663K	﹤0.01%	3376
2014 Q4	–	Sell	-700	Closed	-$13K	–	7274
2014 Q3	$13K	Sell	700 -300	-30%	-$6.41K	﹤0.01%	6732
2014 Q2	$24K	Hold	1,000	–	–	﹤0.01%	6411
2014 Q1	$22K	Buy	+1,000	New	+$21.8K	﹤0.01%	6550
2013 Q3	–	Sell	-4,400	Closed	-$71K	–	7409
2013 Q2	$71K	Buy	+4,400	New	+$76.1K	﹤0.01%	6057

Other funds holding BRKR

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PCA

Pallas Capital Advisors Braintree, Massachusetts $3.25B AUM 40.07% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

SHCM

Sachem Head Capital Management New York $4.82B AUM 73.38% 1-Year Est. Return

Barclays's BRKR Position: Q2 2026 in Review

Barclays reduced its Bruker (BRKR) stake by 4.1% in Q2 2026, selling an estimated $448K and leaving 222,097 shares worth $13.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1334.

Barclays first reported a position in BRKR in Q2 2013 and has held it in 53 quarters since. The position peaked at $13.6M in Q4 2025. 417 funds tracked by Wall St. Rank hold BRKR as of Q2 2026.

Barclays held 222,097 shares of Bruker worth $13.4M as of Q2 2026.
Barclays sold 9,599 Bruker shares in Q2 2026, an estimated $448K.
Bruker made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #1334 holding.
Barclays first reported a position in Bruker in Q2 2013 and has held it in 53 quarters since.
Barclays's Bruker position peaked at $13.6M in Q4 2025.
417 funds tracked by Wall St. Rank held Bruker as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.